CEO in Question Was Personally Thesis

Open, View, and/or
Download this Document

Total Length: 312 words ( 1 double-spaced pages)

Total Sources: 2

The question the article leaves unanswered, though, it what such a classification would look like. Where should such a line be drawn, on what grounds and for what purpose? These are key questions for marketing, since it is an issue of industry-wide branding.

Biotech firms need to ask themselves why they wish to be decoupled from pharmaceutical companies. They also need to ask what the benefits and costs associated with such a move are. Such a move may, for example, exacerbate the ongoing situation with respect to a lack of venture capital.

Stuck Writing Your "CEO in Question Was Personally" Thesis?

View All Our Example CEO in Question Was Personally Thesis

Have A Custom Example Essay Written

A biotech firm is attractive to the extent that venture capitalists believe the firm can hit a home run. To an extent, decoupling from big pharma sends a signal to VCs that the biotech industry lacks those types of big league ambitions. This could be a major obstacle to rebranding biopharm, but the issue is an interesting one and well….....

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"CEO In Question Was Personally" (2009, October 23) Retrieved June 5, 2026, from
https://www.aceyourpaper.com/essays/ceo-question-personally-18336

Latest MLA Format (8th edition)

Copy Reference
"CEO In Question Was Personally" 23 October 2009. Web.5 June. 2026. <
https://www.aceyourpaper.com/essays/ceo-question-personally-18336>

Latest Chicago Format (16th edition)

Copy Reference
"CEO In Question Was Personally", 23 October 2009, Accessed.5 June. 2026,
https://www.aceyourpaper.com/essays/ceo-question-personally-18336
   

Open, View, and/or
Download this Document
order custom essay example